Digital Biomarkers Market Size Report Segmented by Product (Wearables, Mobile Applications, Sensors, Software), Application (Diagnosis, Monitoring), Therapeutic Area (CVDs, Psychiatric & Behavioural Health) Forecast to 2030

Request Quote Download FREE Sample
Single User

Table of Contents

  1. Introduction
    • Introduction
    • Market Scope
      • Market Definition
      • Segments Covered
      • Regional Segmentation
    • Research Timeframe
    • Currency Considered
    • Study Limitations
    • Stakeholders
    • List of Abbreviations
    • Key Conferences and Events (2025-2026)
  2. Research Methodology
    • Secondary Research
    • Primary Research
    • Market Estimation
      • Bottom-Up Approach
      • Top-Down Approach
    • Market Forecasting
  3. Executive Summary
    • Digital Biomarkers Market Snapshot (2025-2030)
    • Segment Overview
    • Regional Snapshot
    • Competitive In"4">
    • Market Overview
      • Market Dynamics
        • Drivers
          • Rising prevalence of chronic diseases
          • Growing adoption of wearables and smart devices
          • Shift toward personalized and preventive healthcare
          • Advancements in AI and machine learning
          • Pharmaceutical industry's demand for efficient clinical trials
        • Restraints
          • Data privacy and security concerns
          • Lack of standardization and validation protocols
          • Limited reimbursement and coverage policies
          • Integration challenges with existing healthcare systems
        • Opportunities
          • Expansion of remote patient monitoring and telehealth
          • Use in neurodegenerative and mental health conditions
          • Increased funding and start-up activity
          • Role in predictive and preventive medicine
        • Key Market Trends
          • Growth of remote and decentralized clinical trials
          • Collaborations betma and tech companies
          • Focus on real-world evidence (RWE)
        • Unmet Market Needs
        • Industry Speaks
  1. Global Digital Biomarkers Market Size & Forecast (2023-2030), By Product, USD Million
    • Introduction
    • Wearable Devices
    • Mobile Applications
    • Sensors
    • Software & Platforms
  2. Global Digital Biomarkers Market Size & Forecast (2023-2030), By Application, USD Million
    • Introduction
    • Disease Diagnosis
    • Monitoring & Management
    • Drug Development & Clinical Trials
    • Predictive Risk Analysis
    • Behavioural & Cognitive Assessment
    • Others
  3. Global Digital Biomarkers Market Size & Forecast (2023-2030), By Therapeutic Area, USD Million
    • Introduction
    • Neurological Disorders
    • Cardiovascular Diseases
    • Diabetes & Metabolic Disorders
    • Respiratory Diseases
    • Psycric & Behavioural Health
    • Sleep Disorders
    • Others
  4. Global Digital Biomarkers Market Size & Forecast (2023-2030), By End User, USD Million
    • Introduction
    • Pharmaceutical & Biotech Companies
    • Healthcare Providers
    • Healthcare Payers
    • Others
  5. Global Digital Biomarkers Market Size & Forecast (2023-2030), By Region, USD Million
    • Introduction
    • North America Digital Biomarkers Market Size & Forecast (2023-2030), By Country, USD Million
      • US
        • Market Size & Forecast, By Product (USD Million)
        • Market Size & Forecast, By Application (USD Million)
        • Market Size & Forecast, By Therapeutic Area (USD Million)
        • Market Size & Forecast, By End User (USD Million)
      • Canada
        • Market Size & Forecast, By Producti>
        • Market Size & Forecast, By Application (USD Million)
        • Market Size & Forecast, By Therapeutic Area (USD Million)
        • Market Size & Forecast, By End User (USD Million)
    • Europe Digital Biomarkers Market Size & Forecast (2023-2030), By Country, USD Million
      • UK
        • Market Size & Forecast, By Product (USD Million)
        • Market Size & Forecast, By Application (USD Million)
        • Market Size & Forecast, By Therapeutic Area (USD Million)
        • Market Size & Forecast, By End User (USD Million)
      • Germany
        • Market Size & Forecast, By Product (USD Million)
        • Market Size & Forecast, By Application (USD Million)
        • Market Size & Forecast, By Therapeutic Area (USD Million)
        • Market Size & Forecast, By End User (USD Million)
      • France
        • Market Size & Forecast, By Product (USD Million)trecast, By Application (USD Million)
        • Market Size & Forecast, By Therapeutic Area (USD Million)
        • Market Size & Forecast, By End User (USD Million)
      • Italy
        • Market Size & Forecast, By Product (USD Million)
        • Market Size & Forecast, By Application (USD Million)
        • Market Size & Forecast, By Therapeutic Area (USD Million)
        • Market Size & Forecast, By End User (USD Million)
      • Spain
        • Market Size & Forecast, By Product (USD Million)
        • Market Size & Forecast, By Application (USD Million)
        • Market Size & Forecast, By Therapeutic Area (USD Million)
        • Market Size & Forecast, By End User (USD Million)
      • Rest of Europe
        • Market Size & Forecast, By Product (USD Million)
        • Market Size & Forecast, By Application (USD Million)
        • Market Size & Forecast, By Therapeutic Area (US & Forecast, By End User (USD Million)
    • Asia Pacific (APAC) Digital Biomarkers Market Size & Forecast (2023-2030), By Country, USD Million
      • China
        • Market Size & Forecast, By Product (USD Million)
        • Market Size & Forecast, By Application (USD Million)
        • Market Size & Forecast, By Therapeutic Area (USD Million)
        • Market Size & Forecast, By End User (USD Million)
      • Japan
        • Market Size & Forecast, By Product (USD Million)
        • Market Size & Forecast, By Application (USD Million)
        • Market Size & Forecast, By Therapeutic Area (USD Million)
        • Market Size & Forecast, By End User (USD Million)
      • India
        • Market Size & Forecast, By Product (USD Million)
        • Market Size & Forecast, By Application (USD Million)
        • Market Size & Forecast, By Therapeutic Area (USD Million)
      • Rest of Asia Pacific
        • Market Size & Forecast, By Product (USD Million)
        • Market Size & Forecast, By Application (USD Million)
        • Market Size & Forecast, By Therapeutic Area (USD Million)
        • Market Size & Forecast, By End User (USD Million)
    • Latin America (LATAM) Digital Biomarkers Market Size & Forecast (2023-2030), USD Million
      • Market Size & Forecast, By Product (USD Million)
      • Market Size & Forecast, By Application (USD Million)
      • Market Size & Forecast, By Therapeutic Area (USD Million)
      • Market Size & Forecast, By End User (USD Million)
    • Middle East & Africa (MEA) Digital Biomarkers Market Size & Forecast (2023-2030), USD Million
      • Market Size & Forecast, By Product (USD Million)
      • Market Size & Forecast, By Application (USD Million)
      • By Therapeutic Area (USD Million)
      • Market Size & Forecast, By End User (USD Million)
  1. Competitive Landscape
    • Key Players and their Competitive Positioning
      • Key Player Comparison
      • Segment-wise Player Mapping
      • Market Share Analysis (2024)
      • Company Categorization Matrix
        • Dominants/Leaders
        • New Entrants
        • Emerging Players
        • Innovative Players
      • Key Strategies Assessment, By Player (2022-2025)
        • New Product Launches
        • Partnerships, Agreements, & Collaborations
        • Mergers & Acquisitions
        • Geographic Expansion
  1. Company Profiles*

(Business Overview, Financial Performance**, Products Offered, Recent Developments)

  • BioSensics
  • ActiGraph, LLC.
  • AliveCor, Inc.
  • Koneksa Health
  • Altoida
  • Amgen Inc.
  • Biogen
  • Empatica Inc.
  • IXICO plc
  • Neurotrack Technologies, Inc.
  • Other Prominent Players

Note: *Indicative list

**For listed companies